Press Releases LumiraDx Limited

Equities

LMDXF

KYG5709L1095

Market Closed - OTC Markets Other stock markets 01:29:23 04/05/2024 am IST			5-day change	1st Jan Change
0.025 ^USD	+17.70%		+47.06%	-60.25%

08/01	Top Midday Decliners	MT
08/01	LumiraDx Limited(OTCPK:LMDX.F) dropped from NASDAQ Composite Index	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stocks Commence 2024 Bullish Rally: LMDX, HNRC, BULT, HALB, SPZI	08/01	AQ
LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th	06/01	GL
Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform	02/01	AQ
LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche	30/12	GL
LumiraDx : EXPLANATORY NOTE - Form 6-K	30/12	PU
LumiraDx : EXPLANATORY NOTE - Form 6-K	11/12	PU
LumiraDx : EXPLANATORY NOTE - Form 6-K	21/11	PU
LumiraDx : EXPLANATORY NOTE - Form 6-K	06/11	PU
LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal	28/23/28	GL
Catheter Precision Inc. (NYSEAMERICAN: VTAK) Revolutionizing Heart Health, VTAK, LMDX, AKU, INPX, AZN	27/23/27	AQ
BigTime Penny Stocks: Low-Priced Small-Cap Stocks (IVP, LMDX, GROM, GCTK, UFAB)	23/23/23	AQ
LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub	21/23/21	AQ
LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub	21/23/21	GL
LumiraDx : INDEX TO FINANCIAL STATEMENTS - Form 6-K	03/23/03	PU
LumiraDx : EXPLANATORY NOTE - Form 6-K	19/23/19	PU
LumiraDx Reports Second Quarter 2023 Results	24/23/24	GL
LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24	17/23/17	GL
CapitalGainsReport Potential Breakouts Watchlist (SHGI, IQST, PHUN LMDX)	01/23/01	AQ
LumiraDx’s Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and Tests	31/23/31	GL
LumiraDx : EXPLANATORY NOTE - Form 6-K	21/23/21	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases LumiraDx Limited

Equities

LMDXF

KYG5709L1095

Press Releases

Filters